XML 74 R59.htm IDEA: XBRL DOCUMENT v3.7.0.1
Summary of Significant Accounting Policies, Net Income Per Share (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2015
Reconciliation of basic and diluted net income per share [Abstract]                      
Net income $ 9,812,000 $ 11,110,000 $ 9,143,000 $ 7,508,000 $ 2,297,000 $ 7,748,000 $ (1,392,000) $ 1,910,000 $ 37,573,000 $ 10,563,000 $ 11,453,000
Basic shares (in shares)                 18,608,812 18,233,163 16,734,539
Effect of dilutive stock options and warrants (in shares)                 809,894 832,930 871,401
Diluted shares (in shares)                 19,418,706 19,066,093 17,605,940
Net income per share [Abstract]                      
Basic net income per share (in dollars per share) $ 0.53 $ 0.59 $ 0.49 $ 0.40 $ 0.12 $ 0.42 $ (0.08) $ 0.11 $ 2.02 $ 0.58 $ 0.68
Diluted net income per share (in dollars per share) 0.50 $ 0.57 $ 0.47 $ 0.39 0.12 $ 0.41 $ (0.08) $ 0.10 $ 1.93 $ 0.55 $ 0.65
Options [Member]                      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Antidilutive securities excluded from effect of dilutive options and warrants (in shares)                 293,239 1,100 0
Exercise price (in dollars per share)         $ 34.17         $ 34.17  
Options [Member] | Minimum [Member]                      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Exercise price (in dollars per share) 28.68               $ 28.68    
Options [Member] | Maximum [Member]                      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Exercise price (in dollars per share) $ 34.17               $ 34.17    
Warrants [Member]                      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Antidilutive securities excluded from effect of dilutive options and warrants (in shares)                     0